Cathepsin K (CTSK), a proteolytic enzyme that degradesthe extracellularmatrix, is recognized as a significant therapeutic target for osteoporosis,osteoarthritis, and rheumatoid arthritis. The gene discussed is CTSK; the disease is osteoporosis.